What is the recommended dose of Diflucan (fluconazole) for a patient diagnosed with tinea, not a yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole Dosing for Tinea Infections

For tinea corporis and tinea cruris, fluconazole 150 mg once weekly for 2-4 weeks is the recommended oral regimen, while tinea pedis typically requires 150 mg once weekly for 4 weeks. 1, 2

Tinea Corporis and Tinea Cruris (Body and Groin)

  • Fluconazole 150 mg once weekly for 2-4 weeks is highly effective, achieving 95% clinical and mycological cure rates in clinical trials 1
  • Most patients (70%) require only 2 weekly doses, with 20% needing 3 doses and 10% requiring the full 4 doses 2
  • This once-weekly regimen is possible because fluconazole achieves high concentrations in the stratum corneum with a long elimination half-life 1
  • Alternative daily dosing of 50-100 mg fluconazole for 2-3 weeks is also effective 3

Tinea Pedis (Foot)

  • Fluconazole 150 mg once weekly requires longer treatment duration, with 60% of patients needing 4 weekly doses 2
  • Clinical cure rates are 70% with mycological eradication in 75% of cases at long-term follow-up 2
  • The pulse dosing regimen of 150 mg once weekly has been validated as effective for tinea pedis 3

Tinea Capitis (Scalp) - Pediatric Consideration

  • For children with tinea capitis, fluconazole 6-8 mg/kg once weekly for 8-12 weeks is effective for Trichophyton species 4, 5
  • An alternative shorter regimen is 6 mg/kg daily for 2-3 weeks, achieving 88% cure rates 5
  • Microsporum canis infections may require up to 16 weeks of once-weekly dosing 4

Critical Clinical Caveats

  • These tinea dosing regimens are fundamentally different from Candida (yeast) infections, which require higher daily doses (200-400 mg daily) and longer treatment courses 6
  • The once-weekly 150 mg regimen exploits fluconazole's unique pharmacokinetics in skin tissue but would be inadequate for systemic or mucosal Candida infections 1
  • Treatment is well-tolerated with minimal adverse effects (primarily mild gastrointestinal complaints in <5% of patients) 1, 2, 4
  • Topical azole therapy (clotrimazole 1% cream twice daily for 2-4 weeks) remains first-line for localized tinea infections, with oral fluconazole reserved for extensive disease, multiple sites, or treatment failures 7

Monitoring and Follow-up

  • Clinical and mycological assessment should occur 3-4 weeks after completing treatment to confirm cure 1, 2
  • If inadequate response is seen at weekly follow-up visits, additional weekly doses can be administered up to a maximum of 4 total doses 2
  • Relapse rates are low (5% for tinea corporis/cruris, 15% for tinea pedis) when adequate treatment duration is completed 2

References

Research

Fluconazole in the treatment of tinea corporis and tinea cruris.

Dermatology (Basel, Switzerland), 1998

Research

Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Fungal Rash to Groin and Scrotum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.